Equilibrium dynamics of β-N-methylamino-L-alanine (BMAA) and its carbamate adducts at physiological conditions

David Zimmerman, Joy J. Goto, Viswanathan V Krishnan

Research output: Contribution to journalArticle

7 Scopus citations

Abstract

Elevated incidences of Amyotrophic Lateral Sclerosis/Parkinsonism Dementia complex (ALS/PDC) is associated with β-methylamino-L-alanine (BMAA), a non-protein amino acid. In particular, the native Chamorro people living in the island of Guam were exposed to BMAA by consuming a diet based on the cycad seeds. Carbamylated forms of BMAA are glutamate analogues. The mechanism of neurotoxicity of the BMAA is not completely understood, and BMAA acting as a glutamate receptor agonist may lead to excitotoxicity that interferes with glutamate transport systems. Though the interaction of BMAA with bicarbonate is known to produce carbamate adducts, here we demonstrate that BMAA and its primary and secondary adducts coexist in solution and undergoes a chemical exchange among them. Furthermore, we determined the rates of formation/cleavage of the carbamate adducts under equilibrium conditions using two-dimensional proton exchange NMR spectroscopy (EXSY). The coexistence of the multiple forms of BMAA at physiological conditions adds to the complexity of the mechanisms by which BMAA functions as a neurotoxin.

Original languageEnglish (US)
Article numbere0160491
JournalPLoS One
Volume11
Issue number8
DOIs
StatePublished - Aug 1 2016

ASJC Scopus subject areas

  • Agricultural and Biological Sciences(all)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Medicine(all)

Fingerprint Dive into the research topics of 'Equilibrium dynamics of β-N-methylamino-L-alanine (BMAA) and its carbamate adducts at physiological conditions'. Together they form a unique fingerprint.

  • Cite this